Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,891.00
Bid: 1,887.00
Ask: 1,889.00
Change: 16.00 (0.85%)
Spread: 2.00 (0.106%)
Open: 1,897.00
High: 1,897.00
Low: 1,877.00
Prev. Close: 1,875.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET PRE-OPEN: Lower Call As AstraZeneca Earnings Slip

Fri, 18th May 2018 07:42

LONDON (Alliance News) - Stock prices in London are seen opening marginally lower on Friday after the FTSE 100 set a record closing high on Thursday, as AstraZeneca reported a drop in earnings for the first quarter. IG futures indicate the FTSE 100 index is to open down 4.77 points at 7,783.20. The blue chip index closed up 0.7% at 7,787.97 on Thursday.In early corporate news, Anglo-Swedish drugmaker AstraZeneca said its performance in product sales benefited from strong launches and continued growth of newer medicines in China, but was hurt by lower sales of its cholesterol drug Crestor due to generic competition. For the quarter ending March 31, revenue was down 4.0% to USD5.18 billion from USD5.40 billion in the first quarter last year. Product sales rose 3% at actual exchange rates to USD4.98 billion, but the group added that product sales growth this year is weighted to the second half.Pretax profit declined 36% USD374 million against USD582 million. "AstraZeneca's pipeline continued to bring significant benefits for patients, most recently with the expanded US approval of Tagrisso for lung cancer and Lynparza for breast cancer. With our transformation coming into sharper commercial focus as the year progresses, we are confident of delivering on our goals," said Chief Executive Pascal Soriot. Jordan-founded generic drugmaker Hikma Pharmaceuticals said it has made an encouraging start to the year, with its Global Injectables unit performing well, The division was supported by six product launches in the year, and "strong quality track record enabling to meet increased demand across our marketed portfolio", the company added. "Our efforts to reduce costs across the group are on track and we continue to focus on enhancing and investing in our pipeline. Our cash position remains very healthy and our balance sheet is strong. Altogether, these factors reinforce our positive outlook for the Group and enable us to reiterate our guidance for the full year," said CEO Siggi Olafsson.Oil companies BP and ConocoPhillips are in discussions for an asset swap deal that would see the UK energy major gain a greater foothold in a key project in the North Sea and the US explorer get Alaskan assets, the Bloomberg reported citing people familiar with the matter.BP is considering taking Conoco's stake in the Clair field, in which BP already holds a 28.6% stake and is the operator, according to the financial news service. BP describes Clair as "the largest undeveloped hydrocarbon resource" in the UK.Elsewhere, Unite Group said Property Director Richard Simpson will leave the student accommodation developer to take the CEO role at student accommodation builder Watkin Jones. Simpson will remain with Unite until December and take up his new position at Watkin Jones in January. Ophir Energy said CEO Nick Cooper has stepped down effective immediately, Non-Executive Director Alan Booth will assume the role of interim CEO until a replacement is found. "This decision to appoint a new CEO reflects the company's ongoing move to rebalance its portfolio towards a larger production and cash flow base, to support more focused and sustainable exploration activity," Ophir said. Sterling was flat quoted at USD1.3516 early Friday, versus USD1.3510 at the London equities close on Thursday.In the economic events calendar on Friday there is eurozone trade data at 1000 BST.In the US on Thursday, Wall Street ended lower, with the Dow Jones Industrial Average closing down 0.2%, S&P 500 down 0.1% and Nasdaq Composite ending 0.2% lower.Stocks in the US closed lower on Thursday as traders expressed some uncertainty about the second round of trade talks between the US and China.Blaming the trade policies of previous administrations, US President Donald Trump expressed some doubt about whether the high-level trade talks with China will be successful.Trump told reporters he tends to doubt the talks will be successful in remarks during an Oval Office meeting with NATO Secretary General Jens Stoltenberg."The reason I doubt it is because China has become very spoiled," Trump said. "The EU has become very spoiled. Other countries have become very spoiled, because they always got 100% of whatever they wanted from the US."The Japanese Nikkei 225 index closed up 0.3% Friday. In China, the Shanghai Composite is up 0.8%, while the Hang Seng index in Hong Kong is up 0.5%.In Asian economic news, nationwide consumer prices in Japan were up just 0.6% on year in April, the Ministry of Internal Affairs and Communications said. That was shy of expectations for a gain of 0.7% and was down sharply from 1.1% in March.Core CPI was up 0.7% on year, beneath forecasts for 0.8% and down from 0.9% in the previous month. On a monthly basis, overall CPI was down 0.4% and core CPI eased 0.1%.
More News
18 Dec 2020 12:08

LONDON MARKET MIDDAY: FTSE 100 Rises As Crunch Brexit Talks Dent Pound

LONDON MARKET MIDDAY: FTSE 100 Rises As Crunch Brexit Talks Dent Pound

Read more
18 Dec 2020 10:45

UK WINNERS & LOSERS SUMMARY: US Generic Advair Ok Lifts Hikma, Vectura

UK WINNERS & LOSERS SUMMARY: US Generic Advair Ok Lifts Hikma, Vectura

Read more
18 Dec 2020 08:12

Hikma rallies as it launches generic version of Glaxo asthma treatment

(Sharecast News) - Hikma Pharmaceuticals shares rallied after the company said it had received approval from the US Food and Drug Administration and launched its generic version of GlaxoSmithKline's asthma treatment, Advair Diskus.

Read more
17 Dec 2020 18:10

Hikma Pharmaceuticals Gets US FDA Approval For Generic Advair Diskus

Hikma Pharmaceuticals Gets US FDA Approval For Generic Advair Diskus

Read more
2 Dec 2020 13:11

Wednesday broker round-up

(Sharecast News) - Royal Dutch Shell A: JP Morgan upgrades to overweight with a target price of 1,700p.

Read more
24 Nov 2020 13:33

Tuesday broker round-up

(Sharecast News) - Glencore: Jefferies upgrades to buy with a target price of 250p.

Read more
10 Nov 2020 13:17

Tuesday broker round-up

(Sharecast News) - On the Beach: Citigroup downgrades to neutral with a target price of 370p.

Read more
10 Nov 2020 09:44

UK BROKER RATINGS SUMMARY: Investec Cuts Barclays; Goldman Raises Next

UK BROKER RATINGS SUMMARY: Investec Cuts Barclays; Goldman Raises Next

Read more
5 Nov 2020 10:44

TOP NEWS: Hikma Lifts Annual Guidance; Launches Generic Drug In US

TOP NEWS: Hikma Lifts Annual Guidance; Launches Generic Drug In US

Read more
5 Nov 2020 09:24

LONDON MARKET OPEN: Pound Keeps Lid On FTSE 100 As BoE Boosts Support

LONDON MARKET OPEN: Pound Keeps Lid On FTSE 100 As BoE Boosts Support

Read more
5 Nov 2020 09:15

Hikma raises FY guidance for generics unit following positive H1 momentum

(Sharecast News) - Pharmaceutical company Hikma said on Thursday that the group as a whole was "performing well" and had maintained the positive momentum seen in the first half, leading it to reiterate guidance for one unit and raise it on another.

Read more
4 Nov 2020 17:06

LONDON MARKET CLOSE: Strong End To Choppy Session On Tight US Poll

LONDON MARKET CLOSE: Strong End To Choppy Session On Tight US Poll

Read more
4 Nov 2020 12:12

LONDON MARKET MIDDAY: Stocks In Europe Shake Off US Poll Uncertainty

LONDON MARKET MIDDAY: Stocks In Europe Shake Off US Poll Uncertainty

Read more
4 Nov 2020 10:38

UK WINNERS & LOSERS SUMMARY: Pharmaceutical Firms Rally

UK WINNERS & LOSERS SUMMARY: Pharmaceutical Firms Rally

Read more
29 Oct 2020 16:02

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.